Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China · Delayed Price · Currency is CNY 9.19
+0.11 (1.21%)
At close: Feb 3, 2026
SHA:600789 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 188.75 | 394.62 | 246.17 | 138.01 | 89.1 | 227.88 |
Depreciation & Amortization | 399.01 | 399.01 | 381.13 | 348.12 | 307.46 | 243.93 |
Other Amortization | 3 | 3 | 1.44 | 1.88 | 2.25 | 1.54 |
Loss (Gain) From Sale of Assets | -153.42 | -153.42 | -0.28 | -2.83 | -0.16 | -201.04 |
Asset Writedown & Restructuring Costs | 133.82 | 133.82 | 109.36 | 1 | 0.68 | 0.16 |
Loss (Gain) From Sale of Investments | 7.56 | 7.56 | 7.2 | 6.53 | 3.18 | -2.54 |
Provision & Write-off of Bad Debts | 2.52 | 2.52 | 0.98 | 8.42 | 24.39 | 8.12 |
Other Operating Activities | 132.98 | 25.89 | 32.83 | 163.54 | 113.83 | 89.42 |
Change in Accounts Receivable | -265.44 | -265.44 | -124.56 | -516.07 | -83.45 | -517.64 |
Change in Inventory | -145.06 | -145.06 | 7.62 | -314.68 | -356.13 | -26.79 |
Change in Accounts Payable | -7.36 | -7.36 | -53.29 | 614.77 | 78.61 | 408.26 |
Change in Other Net Operating Assets | 0.69 | 0.69 | 0.45 | - | - | - |
Operating Cash Flow | 304.05 | 402.82 | 604.01 | 444.38 | 177.49 | 234.55 |
Operating Cash Flow Growth | -44.53% | -33.31% | 35.92% | 150.36% | -24.33% | -35.18% |
Capital Expenditures | -324.28 | -279.18 | -337.91 | -428.36 | -488.57 | -703.12 |
Sale of Property, Plant & Equipment | 94.86 | 20.31 | 0.03 | 0.15 | 1.34 | 217.3 |
Divestitures | - | - | 2.13 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | - | -26.85 |
Investment in Securities | - | - | - | -15.82 | -42.18 | -45.39 |
Other Investing Activities | 32.76 | - | -34.03 | 0.03 | -4.99 | 0.12 |
Investing Cash Flow | -196.66 | -258.87 | -369.78 | -444.01 | -534.4 | -557.93 |
Short-Term Debt Issued | - | - | - | - | - | 70.69 |
Long-Term Debt Issued | - | 1,676 | 2,179 | 2,145 | 2,577 | 2,282 |
Total Debt Issued | 2,122 | 1,676 | 2,179 | 2,145 | 2,577 | 2,353 |
Short-Term Debt Repaid | - | - | - | - | - | -70.88 |
Long-Term Debt Repaid | - | -1,814 | -2,198 | -1,973 | -2,144 | -1,969 |
Total Debt Repaid | -2,198 | -1,814 | -2,198 | -1,973 | -2,144 | -2,040 |
Net Debt Issued (Repaid) | -75.41 | -137.41 | -18.57 | 171.81 | 432.68 | 312.98 |
Issuance of Common Stock | - | 17.36 | 61.88 | 41.76 | 1.98 | - |
Common Dividends Paid | -235.48 | -233.49 | -143.73 | -139.59 | -166.39 | -117.66 |
Other Financing Activities | 164.44 | 164.44 | 6.5 | -79.29 | -6.95 | 2 |
Financing Cash Flow | -146.45 | -189.1 | -93.92 | -5.31 | 261.32 | 197.31 |
Foreign Exchange Rate Adjustments | 9.84 | 10.81 | 2.7 | 6.46 | 0.83 | -1.28 |
Net Cash Flow | -29.22 | -34.34 | 143.01 | 1.52 | -94.76 | -127.34 |
Free Cash Flow | -20.23 | 123.64 | 266.09 | 16.02 | -311.07 | -468.57 |
Free Cash Flow Growth | - | -53.54% | 1561.36% | - | - | - |
Free Cash Flow Margin | -0.33% | 1.98% | 4.33% | 0.29% | -6.32% | -11.14% |
Free Cash Flow Per Share | -0.02 | 0.14 | 0.30 | 0.02 | -0.35 | -0.51 |
Cash Income Tax Paid | 153.24 | 130.55 | 231.16 | 65.86 | 104.04 | 43.21 |
Levered Free Cash Flow | -88.85 | -253.58 | -59 | -39.51 | -436.35 | -702.59 |
Unlevered Free Cash Flow | -46.67 | -206.47 | -9.51 | 21.77 | -395.64 | -663 |
Change in Working Capital | -410.17 | -410.17 | -174.83 | -220.3 | -363.25 | -132.92 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.